Stepwise decline in visual field after serial sildenafil use

J Neuroophthalmol. 2008 Mar;28(1):76-7. doi: 10.1097/WNO.0b013e31816743da.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amlodipine / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Drug Interactions / physiology
  • Erectile Dysfunction / drug therapy
  • Humans
  • Hypertension / drug therapy
  • Male
  • Middle Aged
  • Optic Nerve / blood supply
  • Optic Nerve / drug effects
  • Optic Nerve / physiopathology
  • Optic Neuropathy, Ischemic / chemically induced*
  • Optic Neuropathy, Ischemic / diagnosis
  • Optic Neuropathy, Ischemic / physiopathology
  • Phosphodiesterase Inhibitors / adverse effects*
  • Piperazines / adverse effects*
  • Prostatectomy / adverse effects
  • Prostatic Neoplasms / surgery
  • Purines / adverse effects
  • Retinal Artery / drug effects
  • Retinal Artery / physiopathology
  • Risk Factors
  • Sildenafil Citrate
  • Sulfones / adverse effects*
  • Time
  • Vision, Low / chemically induced*
  • Vision, Low / diagnosis
  • Vision, Low / physiopathology

Substances

  • Antihypertensive Agents
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Amlodipine
  • Sildenafil Citrate